Danielle Scribani, PA
Surgical · Staten Island, NYNPI 1699251025
Payments from drug & device makers
Across 51 payments — averaging $85.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$1K
- Tactile Systems Technology Inc$760
- Penumbra, Inc.$617
- Medtronic$488
- Bard Peripheral Vascular, Inc.$442
- W. L. Gore & Associates, Inc.$291
- plus $320 from 4 others
What the payments were for
- Travel & lodging$1,06825%
- Food & beverage$3,29275%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 4 | $1,441 |
| Tactile Systems Technology Inc | 23 | $760 |
| Penumbra, Inc. | 5 | $617 |
| Medtronic | 7 | $488 |
| Bard Peripheral Vascular, Inc. | 4 | $442 |
| W. L. Gore & Associates, Inc. | 4 | $291 |
| Silk Road Medical, Inc. | 1 | $163 |
| Integra Lifesciences Corporation | 1 | $78 |
| AstraZeneca | 1 | $42 |
| Shockwave Medical, Inc | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$405
- Flexitouch Plus$297
- Valiant Captivia$176
- GORE VIABAHN VBX Balloon Expandable Endo$175
- ENTRE$166
- ENROUTE Transcarotid Stent$163
- ENROUTE .014 Guidewire$163
- ENHANCE Transcarotid Peripheral Access Kit$163
- ENROUTE Transcarotid Neuroprotection System$163
- Penumbra System$139
- Nimbl$131
- ENDURANT IIS$121
How this compares
$4,360 in reported general payments places this provider in the 90th percentile of 1,544 surgical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 80 | $46,484 |
| EliquisApixaban | 26 | $14,322 |
| SantylCollagenase Clostridium Hist. | 12 | $6,200 |
| Ammonium Lactate | 30 | $451 |
| ClopidogrelClopidogrel Bisulfate | 37 | $237 |
| Gabapentin | 13 | $139 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $71 |
Paid to pharmacies, not to this prescriber.
Other surgical in Staten Island
- Lindsay SchweikarthAlbany$324K
- Nicole FeinNew York$225K
- Kenneth RuizNew York$93K
- Sarah MartineckWilliamsville$87K
- Terry LinNew York$70K
- Beth PhillipsEast Syracuse$51K
- James DoolittleNew York$46K
- Tanya GeistAmherst$43K
- Irina KommNew York$39K
- Alexandra DemeglioNew York$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.